Research

From October, Dr. Alison Mitchell and her Emmy Noether junior research group at the Erlangen Centre for Astroparticle Physics (ECAP) are to investigate the role pulsars play in creating galactic, high-energy cosmic rays. The project is set to run for six years, and has received nearly 1.5 million euros in funding.

The diffuse symptoms at the early stage of complex autoimmune diseases make it hard to diagnose the condition early on, which in turn delays treatment. A team of researchers at FAU has now demonstrated that treatment can be extremely effective if autoimmune diseases are treated as early as possible, even before the first clinical symptoms appear.

Snakes benefited from the mass extinction after the asteroid impact 66 million years ago. The asteroid impact wiped out 95 percent of all life on Earth, including the dinosaurs, and only a few species of snake survived. The lack of predators and their ability to survive for long periods without food helped snakes to spread to other continents and exploit new habitats, allowing a wide variety of new species to develop. The patterns seen in snakes show that natural disasters play a greater role in evolution than previously thought.

The influence of rapid climate change on biodiversity depends to a significant extent on longer-lasting climate trends in previous periods of the Earth’s history.

Although patients with human immunodeficiency virus (HIV) can benefit from treatment that suppresses the virus and thus protects them against AIDS, they usually have more health problems than people not affected by the virus and their life expectancy is lower New studies indicate that increased and ongoing inflammation could be the cause.

An international research team with participants from several universities including the FAU has proposed a standardized registry for artificial intelligence (AI) work in biomedicine to improve the reproducibility of results and create trust in the use of AI algorithms in biomedical research and, in the future, in everyday clinical practice.

After the Department of Ophthalmology at Universitätsklinikum Erlangen announced their global breakthrough in early July 2021 of successfully treating a Long COVID patient (aged 59), two further patients are now on the road to recovery thanks to the drug BC 007. The team at the Department of Ophthalmology has used the approach to treat two more patients.